Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-12-07

FDA Approved: FEBUXOSTAT — Original Application (Ascend Laboratories, LLC)

View source ↗

Summary

The FDA approved Ascend Laboratories, LLC's original application for febuxostat, a generic version of the gout and hyperuricemia medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FEBUXOSTAT (Febuxostat)

Snippet

ORIG AP for FEBUXOSTAT (FEBUXOSTAT)